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ABSTRACT
Members of the tyrosine recombinase (YR) family of
site-specific recombinases catalyze DNA rearrange-
ments using phosphoryl transfer chemistry that is
identical to that used by the type IB topoisomerases
(TopIBs). To better understand the requirements for
YR catalysis and the relationship between the YRs
and the TopIBs, we have analyzed the in vivo and
in vitro recombination activities of all substitutions
of the seven active site residues in Cre recombin-
ase. We have also determined the structure of a
vanadate transition state mimic for the Cre–loxP
reaction that facilitates interpretation of mutant
activities and allows for a comparison with similar
structures from the related topoisomerases. We find
that active site residues shared by the TopIBs are
most sensitive to substitution. Only two, the tyrosine
nucleophile and a conserved lysine residue that ac-
tivates the 50-hydroxyl leaving group, are strictly
required to achieve >5% of wild-type activity. The
two conserved arginine residues each tolerate one
substitution that results in modest recombination
activity and the remaining three active site positions
can be substituted with several alternative amino
acids while retaining a significant amount of
activity. The results are discussed in the context of
YR and TopIB structural models and data from
related YR systems.
INTRODUCTION
Members of the tyrosine recombinase (YR) family of
site-speciﬁc recombinases catalyze a variety of
sequence-speciﬁc DNA rearrangements in biological
systems, including the integration and excision of phage
genomes into and out of their bacterial hosts (1). The
phage   integrase (2), the yeast Flp recombinase (3), the
phage P1 Cre recombinase (4) and the Escherichia coli
XerC/XerD recombinases (5) are examples of well-studied
YR systems. The YR enzymes bind to two distinct,
speciﬁc sequences (e.g. attP and attB for   integrase;
two loxP sites for Cre) and catalyze a stepwise exchange
of strands between the two sites to generate recombinant
products (6).
The site-speciﬁc recombination reaction begins with
cleavage of the recombining sites by conserved tyrosine
residues to form covalent 30-phosphotyrosine linkages to
the DNA substrates and release free 50-hydroxyl groups
(Figure 1A). Reversal of this cleavage reaction restores the
starting conﬁguration and completes a cycle of phosphoryl
transfer chemistry that is identical to that performed by
type Ib topoisomerases (TopIBs; 7). Alternatively, the
strands bearing free 50-hydroxyl groups can be exchanged
between recombining sites and subsequent ligation results
in formation of a four-way Holliday junction (HJ) inter-
mediate. The HJ intermediate can then serve as the sub-
strate for a second round of cleavage, strand exchange and
ligation steps. If the same strands are processed to resolve
the junction, the starting sites are re-generated. If the HJ
intermediate isomerizes to allow processing of the
opposite pair of DNA strands, recombinant products
are formed.
The YR active site is composed of seven conserved
residues (Table 1). In addition to the tyrosine nucleophile,
one lysine and two arginine residues are thought to be
essential for eﬃcient recombination. Two histidine
residues are also found in most YR active sites; one of
these (His/Trp III) is tryptophan in the Cre and Flp
recombinases. The seventh active site residue is either
Glu or Asp in the YR enzymes. A comparison of  100
tyrosine recombinases in 1998 revealed aspects of the
protein sequences that were strongly conserved, that
were similar and that diﬀered among family members
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conservation of the active site residues that includes
data from microbial genomes sequenced over the past
decade, we analyzed over 12000 PsiBlast (9) hits from
the National Center for Biotechnology Information
(NCBI) RefSeq protein database (10) using the Cre re-
combinase catalytic domain as a query sequence. As
shown in Table 1, conservation ranges from the more
variable box II histidine (87%) to the highly conserved
catalytic tyrosine (99.6%) and box II arginine (99.1%).
Two residues (His/Trp III and Glu/Asp I) are present as
one of two alternative amino acid types in the YR
enzymes.
The properties of a number of YR active site mutants
have been described in the literature, including their
ability to catalyze recombination in vivo or in vitro and
to carry out speciﬁc steps of the recombination pathway
such as cleavage, ligation, and synapsis of the recombining
sites. We have compiled a summary of these results in
Table S1 that augments a similar compilation reported
by Nunes-Duby et al. (8). In addition to the biochemical
studies that have been reported for YR systems, a number
of high-resolution structural models are available that
provide snapshots of the enzyme active sites at speciﬁc
steps of recombination (11).
As shown in Figure 1B, TopIBs use a similar strategy of
cleavage with an active site tyrosine to form a
30-phosphotyrosine linkage that allows strand rotation
and relaxation of supercoils. This similarity also extends
to the level of structure and catalytic mechanism, since the
TopIB enzymes have similar catalytic domain folds and
share a subset of the YR active site residues (12). Indeed,
four of the seven active site residues listed in Table 1 are
strictly conserved among the TopIBs. The topoisomerases
encoded by poxviruses are type IB enzymes and the
vaccinia virus TopIB has been extensively studied (7).
Investigations into the function of poxvirus TopIB have
not only been instrumental in developing a mechanistic
understanding for this family of topoisomerases but also
had an important impact on understanding the YR
enzymes. As is the case for the YRs, there are now
several high-resolution crystal structures available for
TopIBs bound to DNA substrates, providing a corres-
ponding set of snapshots of the enzyme active sites at dif-
ferent steps in the phosphoryl transfer reaction. One such
model is a vanadate transition state mimic for both
trypanosomal and variola virus TopIB (13,14) which has
provided additional insight into the nature of TopIB ca-
talysis. A corresponding transition state mimic structure
for a YR system has not yet been reported.
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Figure 1. Tyrosine recombinases and type IB topoisomerases. (A) Tyrosine recombinase strand-exchange mechanism to generate a HJ intermediate.
The HJ intermediate can be converted to starting substrates by exchange of the same strands or to recombinant products by exchange of the second
pair of strands by the remaining two protein subunits. (B) The cleave–rotate–ligate mechanism of supercoil relaxation used by type IB topoisom-
erases. The two enzyme families use nearly identical mechanisms to catalyze the phosphoryl transfer reactions.
Table 1. Tyrosine recombinase and topoisomerase IB active site residues
Arg I Glu/Asp I Lys His II Arg II His/Trp III Tyr
P1 Cre R173 E176 K201 H289 R292 W315 Y324
  Int R212 D215 K235 H308 R311 H333 Y342
S. cerevisiae Flp R191 D194 K223 H305 R308 W330 Y343
E. coli Xer C/D R148 D151 K172 H240/244 R243/247 H243/247 Y275/279
Poxvirus TopIB
a R130 None K167 None
b R223 H265 Y274
Conservation
c 91.2% R 79% E 94.7% K 87.3% H 99.1% R 92% H 99.6% Y
1.1% K 16.4% D 3.8% R 6.8% Y 0.5% K 4% W
Functions
d TS S GAB TS, GAB TS S, TS N
aResidue numbers refer to the vaccinia/variola virus topoisomerases.
bA lysine residue is located in this position of the sequence in the TopIB enzymes, but is directed away from the active site.
cThe values given are based on analysis of PSI-BLAST hits from the NCBI RefSeq database using the Cre catalytic domain as query; the percentages
for the catalytic lysine are estimates, as described in ‘Materials and Methods’ section.
dRoles of active site residues in catalysis, based on published biochemical and structural data and on the work described here.
TS, transition state stabilization; S, structural; GAB, general acid/base catalysis; N, nucleophile.
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have determined the structure of a Cre–DNA–vanadate
transition state mimic, where the active site phosphate
has been replaced by pentavalent vanadium. The transi-
tion state mimic structure allows a more informative in-
terpretation of active site mutant activities and also allows
for a detailed comparison with similar structures from the
TopIB family. To improve our understanding of the re-
quirements for catalysis in the tyrosine recombinases and
the diﬀerences with the closely related TopIB enzymes, we
have created a library of active site mutants for Cre re-
combinase where each of the seven residues listed in
Table 1 has been replaced by all 19 alternatives. Here,
we report the in vivo and in vitro recombination activities
of these mutants. We ﬁnd that despite the high degree of
conservation, many active site substitutions retain a sig-
niﬁcant amount of recombination activity, including one
substitution of an active site arginine previously thought
to be essential for eﬃcient catalysis.
MATERIALS AND METHODS
Reagents and strains
Reagents were obtained from Sigma, unless otherwise
noted. Strains CSH100 (F’ lacproA+,B+(lacI
q lacPL8)/
ara D(gpt-lac)5) and CSH142 (F-/ara D(gpt-lac)5) were
obtained from the E. coli Genetic Stock Center
(CGSC8105 and CGSC8083) at Yale University.
Plasmids pFW11 and pTSA29 were gifts from Dr. Fred
Whipple and Dr. Gregory Phillips, respectively.
Crystallization and diﬀraction data
Cre was over-expressed and puriﬁed as previously
described (15). Oligonucleotides were synthesized by the
Keck Biotechnology Facility at Yale University and
puriﬁed by ion-exchange chromatography. Sodium
orthovanadate (Sigma) was activated as described (16)
and added to a premixed solution containing 40mM Cre,
75mM half-site DNA, 20mM CaCl2, 20mM sodium
acetate, pH 5.6, 1mM dithiothreitol and 25%
2-methyl-2,4-pentanediol (MPD) to a ﬁnal concentration
of 2mM. Crystals were grown by hanging drop vapor
diﬀusion against a well reservoir of 20mM sodium
acetate, pH 5.0, 20mM CaCl2 and 30–45% MPD.
Crystals were ﬂash-frozen in liquid nitrogen prior to
data collection. Diﬀraction data were measured at the
Advanced Light Source beamline 8.2.1 and processed
using HKL2000 (17).
Structure solution and reﬁnement
The structure was determined by molecular replacement
with AMORE (18), using a search model based on the
pre-cleavage synaptic complex (pdb entry 2HOI) where
crossover region DNA and all active site residues had
been removed. Initial rounds of reﬁnement were per-
formed with CNS (19) following model building and ad-
justment with COOT (20). Final reﬁnements were
performed with REFMAC (21). Active site residues, the
vanadate linkage and omitted DNA residues were ﬁt into
clear, unbiased electron density. Vanadate geometry was
restrained during reﬁnement as described for the viral
TopIB–DNA complex (14). Coordinates for the reﬁned
structure have been deposited with the Protein Data
Bank with accession code 3MGV.
Generation of active site mutants
An XbaI–HindIII fragment containing the wild-type Cre
coding sequence was cloned into the same sites of
pBluescriptIIKS+ (Stratagene) and used as a template
for polymerase chain reaction (PCR)-based mutagenesis
using a modiﬁed version of the Phusion protocol (New
England Biolabs; NEB). Most substitutions were
generated using primers with degenerate codons and
those remaining following initial sequencing were
obtained using speciﬁc primers. In both cases, only the
primer containing the altered active site codon was
phosphorylated during oligonucleotide synthesis
(Integrated DNA Technologies; IDT) and a 1-h DpnI di-
gestion following ligation of the PCR products was used
to remove the template. All mutant plasmids were
sequenced twice to verify the correct substitution.
In vivo recombination reporter
A single copy reporter was generated by homologous re-
combination of an intermediate plasmid based on pFW11
into an F’ containing an intact lac operon (22). A modiﬁed
sulA promoter (23) was cloned into the EcoRI and BamHI
sites of pFW11 using oligonucleotides P1 and P2 (Table
S2) and a fragment containing the aadA coding sequence
with a 50-KpnI site was ampliﬁed using primers P3 and P4
and ligated into the BamHI and SalI sites of sulA-FW11
to give pGV1026. A terminator cassette that could be
excised by Cre was generated by inserting the E. coli
rpoC terminator (24) ampliﬁed using primers P5 and P6
into the BsrGI and HincII sites of pGV697, a pBluescript
derivative containing directly repeating loxP sites ﬂanking
an 867-bp segment (GV, unpublished data), to generate
pGV1025. The resulting construct contains loxP sites
ﬂanking a 920-bp segment containing TrpoC. The
excisable element was then inserted into the BamHI–
KpnI sites of pGV1026 to give pGV1035. pGV1035 was
then transformed into CSH100 and double crossovers
were selected following transfer of the recombinant
episome into CSH142/pTSA29 by conjugation as
described (22). pTSA29 provides ampicillin resistance
and a temperature-sensitive pSC101 origin, allowing
facile removal following incubation at 42 C (25). The
relevant segment of the resulting F’ (pGV1048) is shown
schematically in Figure 4A.
In vivo recombination
Cre mutant plasmids were transformed into chemically
competent CSH142/pGV1048 cells and after a one hour
incubationat37 CwereplatedonLBcontainingampicillin
(100mg/ml), kanamycin (35mg/ml) and X-gal (20mg/ml).
An equal volume was plated on LB containing the
same components plus 20mg/ml streptomycin. Activity
was recorded as the ratio of the number of colonies
after 16h at 37 C on the streptomycin plate divided by
Nucleic Acids Research, 2010,Vol.38, No. 17 5819the number on the plate lacking streptomycin. For
wild-type Cre, this ratio was reproducibly close to 1,
with a colony count of  1000. For the empty
pBluescript and Cre Y324F negative controls, the back-
ground was zero; no streptomycin-resistant colonies were
observed in multiple experiments and colonies on the
non-selection plate were white. For weakly active
mutants, where a small number of colonies were
observed on the streptomycin plate, in vivo activity was
corroborated by the appearance of blue colonies in the
absence of streptomycin selection. In vivo assays were
repeated three to four times and the results were
tabulated as a percentage of wild-type activity with
typical standard deviations of 9% for the most weakly
active mutants.
In vitro recombination assay
The substrate for in vitro recombination was a linear
602-bp DNA fragment digested from pBG1701,
dephosphorylated and
32P end-labeled with polynucleo-
tide kinase. pBG1701 was constructed by ligation of a
DNA segment containing two loxP sites ﬂanking a
334-bp spacer, shown schematically in Figure 5A.
Cre-containing lysates were prepared from CSH142/
pGV1048 transformants by sonication of cells from 2ml
culture grown at 37 C to an optical density of  1.0 in
100ml lysis buﬀer (50mM Tris pH 7.4, 150mM NaCl,
2mM dithiothreitol, 1mM ethylenediaminetetraacetic
acid (EDTA), 0.5% Triton-X100 and protease inhibitors).
Cleared lysates were diluted in lysis buﬀer and used
directly for in vitro binding and recombination assays.
Recombination reactions were carried out in 25ml assay
buﬀer (50mM Tris pH 7.4, 150mM NaCl, 2mM
dithiothreitol, 1mM EDTA, 50mg/ml sheared salmon
DNA) containing 200pM labeled substrate and a
50-fold dilution of lysate. After incubation at 37 C for
1h, reactions were quenched with 0.5% sodium dodecyl
sulfate (SDS), heated at 70 C for 1min and digested with
proteinase K for 1h at 37 C. Reactions were analyzed on
a 6% acrylamide gel in 1 TBE for 2h at 10V/cm. Gels
were dried and quantiﬁed on a Phosphorimager. Errors
for the in vitro recombination assays were estimated at 5–
10% of wild-type activity based on multiple repetitions of
a subset of weak and moderately active mutants.
In vitro loxP binding
The probe for electrophoretic mobility shift assays
(EMSAs) was a 64-mer duplex containing the loxP site
ﬂanked by 15-bp G C-rich segments. Ten picomoles of
polyacrylamide gel electrophoresis (PAGE)-puriﬁed top
strand were
32P end-labeled with polynucleotide kinase
and annealed to a puriﬁed, unlabeled bottom strand.
Cleared lysate was added (50:1 ﬁnal dilution) to 200pM
labeled substrate in assay buﬀer and the reactions were
incubated for 30min at 20 C. Binding reactions were
electrophoresed on a 6% polyacrylamide gel (29:1 acryl-
amide:bisacrylamide) in TBE that was pre-run for 10V/cm
for 45min at 20 C prior to loading. The gel was run at
13V/cm for 2h at 20 C, dried, and analyzed with a
phosphoimager.
Tyrosine recombinase sequence alignments
The Cre catalytic domain (residues 134–343) was used as a
query sequence for three iterations of PSI-BLAST (9)
searching of the NCBI RefSeq database (10) and 12049
alignments (maximum E-value=0.01) that included all
seven active site residues were analyzed by quantifying
the amino acid frequency at each of the seven positions.
The catalytic lysine is not well aligned due to its position
in a loop of variable size and sequence. For this residue,
we counted lysine (or arginine) as present at this site if it
was located within ﬁve residues of Cre Lys201 in the align-
ment. We obtained similar results when the   integrase
catalytic domain was used as a search query.
RESULTS
Structure of a Cre–loxP transition state mimic
To trap a vanadate transition state mimic for the Cre–
loxP reaction, we used a symmetric version of the loxP
site where the scissile phosphates are missing in both the
top and bottom strand cleavage positions (Figure 2A). We
chose to symmetrize the more G C-rich half-site of loxP
for these experiments [resulting in a site which we refer to
as loxS1 (26)], which provides a transition state model
depicting the DNA functional groups that would be
present in the initial cleavage step of the reaction (27),
as opposed to the HJ-resolution step later in the
pathway. When activated potassium orthovanadate was
added to the Cre–loxS1 complex, one VO
+
2 equivalent
was incorporated into the active site and covalent
linkages were formed with O30,O 5 0 and Tyr324 as
observed in the related TopIB transition state mimic struc-
tures (13,14).
Crystals of the Cre–loxS1–vanadate complex were
grown from hanging drops using conditions similar to
those used previously for several Cre–DNA structures
(28–30) and diﬀracted to 2.3A ˚ resolution at synchrotron
sources. The structure was determined by molecular re-
placement using the synaptic Cre–DNA complex (26)
lacking active site residues as a search model. A
summary of diﬀraction data and reﬁnement results is
given in Table 2 and electron density within the active
site following reﬁnement is shown in Figure 2B.
The overall structure is similar to that observed in the
pre-cleavage and covalent intermediate Cre–DNA struc-
tures previously described (26,30), with a tetramer of inter-
locked Cre subunits bound to two bent DNA substrates
(Figure 2C and D). With the exception of the active sites,
the protein subunits in the current structure superimpose
well with those in the synaptic complex and covalent inter-
mediate structures, with no signiﬁcant diﬀerences
observed. Our discussion of the transition state mimic
structure will therefore focus only on the active site of
the enzyme.
In principle, vanadate could be incorporated into each
of the four active sites present in the Cre–loxS1 complex
shown in Figure 2C. In the Cre–DNA reaction intermedi-
ate structures that have been reported, two of the active
sites in the Cre tetramer adopt ‘active’ conﬁgurations that
5820 Nucleic Acids Research, 2010,Vol.38, No. 17are poised for catalysis of strand exchange (referred to
here as the ‘activated sites’) and the other two are in
‘inactive’ conﬁgurations (‘inactive sites’) that are not com-
petent to catalyze cleavage of the DNA (31). In the current
structure, vanadium is incorporated only into the
activated sites, reﬂecting the inability of the remaining
two subunits to stabilize a transition state conﬁguration.
With the exception of Tyr324 and Lys201, the protein and
DNA residues involved in coordinating vanadium in the
activated sites (Figure 3) adopt similar positions in the
inactive sites of the Cre–loxS1 complex. Tyr324 is
shifted by 3.5A ˚ in the inactive site relative to the activated
site position and Lys201 is withdrawn from the minor
groove. These alternative conﬁgurations for Tyr324 and
Lys201 are typical of those observed in the inactive sites of
other Cre reaction intermediates and we assume that these
eﬀects are also responsible for preventing stable incorpor-
ation of penta-coordinate vanadium in the inactive sites of
the Cre–DNA complex described here.
In the activated sites, vanadium is coordinated by ﬁve
oxygen atoms in a trigonal bipyramidal arrangement with
Tyr324-OZ and O50 in the axial positions and with O30
and the two non-bridging oxygen atoms in equatorial pos-
itions (Figure 3). The two conserved arginine residues each
make double hydrogen bonding interactions; Arg173
hydrogen bonds to O50 and the non-bridging oxygen cor-
responding to O2P and Arg292 hydrogen bonds to the
Tyr324 phenolic oxygen and to O1P. Lys201 is within
close hydrogen bonding distance of four groups: O50 of
the  1 sugar, N3 of the +1 guanine base, O40 of the  1
sugar and a tightly bound water molecule. Each of these
features is also found in the trypanosomal and viral TopIB
transition state structures (13,14), supporting the close
mechanistic and evolutionary relationship between the
two enzyme families. Several other aspects of the Cre
active site diﬀer from the TopIB enzymes and will be dis-
cussed below in the context of the speciﬁc residues.
Comprehensive analysis of Cre active site substitutions
A number of active site mutants have been previously
described for YR and TopIB enzymes (summarized in
A
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Figure 2. Structure of Cre–DNA–vanadate transition state mimic. (A) Sequence of the DNA substrate used, with vanadium incorporation indicated
by ‘v’. The 14-bp recombinase binding elements that surround the central 6-bp crossover region are shaded. The ‘+1’ and ‘–1’ base pair labels are
used to facilitate comparison with related TopIB structures. (B) Weighted 2Fo–Fc electron density following reﬁnement at 2.3A ˚ resolution. The map
is contoured at 1.2s. Glu176 and His289 are not visible in this view. (C) Overall structure of the synaptic complex, viewed from the N-terminal
domains of the recombinase subunits. The activated subunits containing vanadate linkages are colored green. (D) View of a single Cre subunit bound
to a loxP half-site within the tetrameric complex, rotated from the boxed subunit in (C). The tyrosine linkage to vanadate is circled.
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combined, however, the substitutions that have been
studied for a given active site residue number only 6–7
at most out of the 19 alternatives and, in some cases, rela-
tively conservative substitutions have not been reported.
To establish which Cre active site substitutions would
support recombination, we generated all single site
variants for the residues shown in Table 1 and measured
their ability to catalyze recombination in vivo and in vitro.
To test for recombination activity in bacterial cells, we
designed the single copy reporter shown schematically in
Figure 4A. The aadA streptomycin resistance and lacZYA
genes located on an F0 episome are transcribed from a
strong promoter when an intervening transcriptional ter-
minator has been excised by Cre–loxP recombination, but
full-length transcripts are only produced at low levels
when the terminator is present. Cells that are Lac
  and
harbor the reporter F0 will be sensitive to streptomycin
and Lac
  in the absence of active Cre but will become
streptomycin resistant and Lac
+ when active Cre is
present. For the experiments described here, we used
streptomycin resistance and b-galactosidase activity to
score for Cre-mediated site-speciﬁc recombination.
Growth on minimal lactose plates can also be used and
is more eﬀective in identifying mutants with very low
activity.
To assay for in vivo Cre activity, we transformed E. coli
strain CSH142 containing the reporter F0 with a plasmid
containing a Cre coding sequence (described below) and
compared the number of colonies that formed on plates
containing 20mg/ml streptomycin to the number that
formed on plates lacking streptomycin. Approximately
45min is required for expression of the aadA gene (data
not shown). A 60-min outgrowth prior to plating therefore
provided a  15-min time window for recombination to
occur. To facilitate in vitro mutagenesis and limit in vivo
expression, we cloned the wild-type Cre coding sequence
into pBluescriptIIKS+where it is oriented opposite that of
the lac and bla promoters. Due to the high plasmid copy
number, this promoter-less construct still provides
moderate levels of constitutively expressed Cre. When
we compared Cre expression from this plasmid to basal
Cre expression from uninduced pET21a (T7/lac promoter)
and to a P1 lysogen by western blotting, we were not able
to detect Cre in lysates from the P1 lysogen but could
detect small amounts from pET21a and larger amounts
from pBluescriptIIKS+ (data not shown). EMSAs con-
ﬁrmed that active Cre is present in all three cases and
allowed us to estimate the relative concentrations. Thus,
the plasmid used for Cre expression provides protein levels
that are higher than that found in a P1 lysogen, but much
lower than would be produced by a promoter-driven ex-
pression system.
Using the pBluescriptII-Cre plasmid as template, we
generated all 19 amino acid substitutions at each of the
seven active site residues shown in Table 1. Four of these
(Arg173, Lys201, Arg292 and Tyr324) are strongly
conserved among both the YRs and the TopIB enzymes.
Trp315 is most often a histidine in the YRs and is always
histidine for the TopIBs. The ﬁnal two residues are
Glu176 and His289, both of which are unique to the YR
enzymes. Glutamic acid is favored in the Glu176 position,
although a signiﬁcant number of family members use
aspartic acid. His289 is moderately conserved among the
YRs but is absent from the TopIB proteins. The results of
in vivo recombination for the 134 Cre variants are
summarized in Figure 4B. We found a surprising range
of ﬂexibility at several active site positions, including a
number of mutants that we had not predicted would be
active.
In vitro recombination of Cre mutants
To determine if any of the active site substitutions disrupt
the ability of Cre to bind to the loxP site, we used a
gel-shift assay to test cleared lysates from the transformed
reporter strain (Supplementary Figure S1). The lysates in
these experiments were diluted in binding buﬀer so that
wild-type Cre lysate had similar binding activity as that of
a 4nM Cre control. This allowed a qualitative comparison
of DNA-binding activities in the lysates relative to
wild-type Cre. As shown in Supplementary Figure S1,
the lysates for all substitutions at His289 contain
DNA-binding activities similar to wild-type Cre. Out of
all 134 Cre variants tested, only the Y324T mutant dis-
played a signiﬁcant loxP-binding defect, where the
apparent Kd is more than 10-fold greater than wild-type
Cre. For the remaining mutants, these results indicate that
the Cre variants are being produced in a soluble form that
Table 2. Crystallographic data for the Cre–DNA–vanadate transition
state mimic
Diﬀraction data
Resolution (A ˚ )2 . A ˚
Space group P3221
Unit cell a=136.0A ˚
c=218.4A ˚
Mosaicity ( ) 0.53
Completeness (%) 97.2 (95.4)
Rsym 0.103 (0.462)
Total reﬂections 775986
Unique reﬂections 102079
I/  16.17 (4.15)
Redundancy 7.6 (7.3)
Reﬁnement
Rfree 0.222 (0.285)
Rwork 0.193 (0.238)
Number of atoms 13407
Protein 10204
DNA 2859
Water 346
Average B factors (A ˚ 2)
Protein 27.8
DNA 36.8
Water 25.6
Rmsd
Bond lengths (A ˚ ) 0.01
Bond angles ( ) 1.62
Values in parentheses refers to the highest resolution shell (2.38–2.30A ˚ ).
Rsym=
P
h| Ih – <I>h |/
P
Ih, where <I>h is the average intensity
over the symmetry equivalents.
Rwork includes 95% of the reﬂection data used in reﬁnement.
Rfree includes 5% of the reﬂection data excluded from reﬁnement.
5822 Nucleic Acids Research, 2010,Vol.38, No. 17bind to loxP site DNA, eliminating expression, folding, or
gross DNA-binding defects as explanations for a lack of
recombination activity. For many of the mutants, we
noticed a small, but reproducible variation in mobility of
the shifted EMSA bands that may be caused by subtle
diﬀerences in DNA-bending.
To conﬁrm and extend our ﬁndings from the in vivo
recombination experiments, we tested each Cre mutant
for in vitro recombination, again using lysates from the
transfected reporter strain. In this assay, Cre excises a
334-bp segment ﬂanked by loxP sites in a labeled, linear
substrate, producing an unlabeled 368-bp circle and a
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Figure 3. The Cre–DNA–vanadate transition state mimic active site. (A) Stereo view of the ‘activated’ site where vanadate has been incorporated.
(B) Schematic of the activated site with additional residues and hydrogen bonding interactions indicated. Well-ordered water molecules are drawn as
red spheres in (A) and (B).
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in vitro recombination for the H289 panel are shown in
Figure 5B and a summary of results for all of the active
site substitutions is shown in Figure 5C. In general, there
is good agreement between in vitro and in vivo recombin-
ation, but for mutants with higher levels of activity the
in vitro assay provides better discrimination. For
example, the W315F and W315Y substitutions have
near-wild-type activity in the in vivo assay, but are
shown to have <50% wild-type activity in the in vitro
excision assay. The in vitro recombination experiments
also identiﬁed active site mutants that accumulate
covalent and/or HJ intermediates in excess of wild-type
Cre. These results are summarized in Table 3 and in
Supplementary Figure S2.
Tyr324 substitutions
As anticipated, Tyr324 is strictly required for recombin-
ation. None of the 19 alternative residues showed any de-
tectable recombination activity in vivo or in vitro. The
requirement for tyrosine in this position of the active
site is evident from Figure 3. Whereas some substitutions
could, in principle, fulﬁll a role as nucleophile (e.g. serine,
cysteine, lysine and histidine), the length and shape of the
tyrosine side chain are unique. Indeed, a large superfamily
of site-speciﬁc recombinases uses serine rather than
tyrosine as a nucleophile to catalyze strand exchange by
a related phosphoryl transfer mechanism (6). However,
even if a suitable general base were present to activate a
serine residue for nucleophilic attack in the Cre active site,
it is clear that the side chain of a Y324S substitution is too
short reach the scissile phosphate.
The requirement for tyrosine in the YR and TopIB
active sites may also extend to the identity of the
phenolic hydroxyl group. Semi-synthetic vaccinia virus
TopIB mutants with the tyrosine oxygen replaced by
nitrogen (tyramine) or sulfur (thio-tyrosine) are both
inactive, suggesting a unique requirement for tyrosine in
the cleavage and ligation chemistry catalyzed by this
enzyme superfamily (32).
As noted above, Cre Y324T was the only mutant
identiﬁed that is substantially defective in DNA-binding.
Western blot analysis indicates that this mutant is ex-
pressed in a full-length, soluble form and at levels com-
parable to wild-type Cre (data not shown). It is possible
that this mutant is misfolded or adopts an alternative
structure that is not competent to bind to the loxP site.
Lys201 substitutions
Lys201 is located in the loop that connects conserved
b-strands 2 and 3 in the YRs and in the TopIBs, where
it is inserted into the minor groove near the cleavage site
and hydrogen bonds to the+1 base (30,33). The important
catalytic role of this conserved lysine was ﬁrst
demonstrated for poxvirus TopIB, where 50-bridging
phosphorothiolate DNA substrates were used to show
that this residue is the general acid responsible for activa-
tion of the O50 leaving group during the cleavage step of
the reaction (34). The same conclusion was later reached
for Cre, using a similar approach (35). Accordingly, the
Cre K201A mutant and the corresponding mutants in Flp
and Xer are inactive (36–38). Although Lys201 appears to
be strongly conserved among the YRs, its position in a
variable-length loop creates challenges for identifying the
corresponding residue in large alignments of YR se-
quences (see ‘Materials and Methods’ section).
Consistent with previous studies, none of the Lys201
substitutions in Cre resulted in high recombination
activity. However, several substitutions did have a low
level of recombination activity in vivo, including the
K201R mutant. Since the pKs of lysine and arginine
diﬀer by roughly two log orders, the arginine substitution
would be expected to result in a 100-fold decrease in
cleavage rate based only on its ability to activate the
O50-leaving group. This prediction holds true for
poxvirus TopIB (34) and appears to be approximately
true for Flp (37) and for Cre (this work). However, the
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Figure 4. In vivo recombination activities of Cre active site mutants. (A) F’ reporter used to score in vivo activity. If Cre excises a transcriptional
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5824 Nucleic Acids Research, 2010,Vol.38, No. 17Ala and Asn substitutions at this position also have
weak in vivo activity, despite their lack of ability to par-
ticipate in general acid catalysis. None of the K201 sub-
stitutions showed measurable in vitro recombination
activity.
The Cre transition state mimic structure strongly
supports the biochemical data and related structural
results from the TopIB systems regarding the active site
lysine (13,14,34,39). Lys201 hydrogen bonds directly to
the O50 leaving group as well as to the +1 base, O40 of
the  1 sugar, and a well-ordered water molecule that is
also found in the TopIB transition state mimic structures
(Figure 3). The lysine side chain adopts a fully extended
form, with all four side chain dihedral angles near 180 .
This may explain in part why histidine is ineﬀective in this
position; even if the bulkier imidazole ring could be
accommodated in the minor groove, the e-nitrogen
would fall well short of forming eﬀective hydrogen-
bonding interactions with O50. Although the weak
activity of the arginine substitution can be rationalized,
it is not clear why the Ala and Asn substitutions have a
comparable level of activity in vivo.
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Figure 5. In vitro recombination activities of Cre active site mutants. (A) Schematic of the excision assay. (B) Native PAGE of in vitro recombination
reactions following protein digestion for the H289 panel of substitutions. In addition to the 602bp substrate (labeled ‘S’) and the 234bp product
(labeled ‘P’), a band corresponding to a covalent Cre–DNA intermediate can be observed migrating slightly above the product band for some
mutants. This is a nicked 234-bp covalent 30-phosphotyrosine adduct. The corresponding covalent intermediate associated with the substrate is not
well resolved. Identiﬁcation of covalent and HJ intermediate bands are described in more detail in Supplementary Figure S2. (C)I n vitro recom-
bination results. Activity deﬁnitions: 0: no activity observed; +: <5% wild-type, + +: 5-50% wild-type, + + +: >50% wild-type.
Table 3. Accumulation of Holliday junction and covalent intermediates during in vitro recombination
a
ACDE FGH I KL M N P Q R S T V W Y
Y324 HJ +
cov +
K201 HJ +
cov +
R173 HJ + ++
cov + ++
R292 HJ + ++ +
cov + + ++
W315 HJ + + + ++ + +
cov ++
H289 HJ + ++ + + +++ ++ + +++ + +
cov ++ ++ + + +
E176 HJ + + ++ + ++ + +++ + ++ + ++ + ++ ++ ++ ++ + ++ ++ ++
cov ++ + +
Levels reported are after a 60-min reaction.
aKey: +indicates levels similar to wild-type Cre; + + indicates >2  wild-type; + + + indicates >4  wild-type.
Nucleic Acids Research, 2010,Vol.38, No. 17 5825Arg173 substitutions
Arg173 is strongly conserved among the tyrosine recom-
binase and TopIB enzymes and conservative lysine
substitutions in this position show greatly diminished
in vitro catalytic activity in the systems that have
been tested (Table S1). Mutagenesis and biochemical
experiments with poxvirus TopIB indicated a role in
transition state stabilization for Arg130 and this idea
was well supported by subsequent Cre–DNA and
human TopIB–DNA crystal structures, where this
arginine was observed making a double hydrogen-
bonding contact to the scissile phosphate in the covalent
intermediate of the reaction (30,33). More recent
experiments using bridging phosphorothiolate substrates
further indicated a role in leaving group activation,
inasmuch as the poxvirus TopIB R130K mutant showed
a substantial thio-eﬀect (39). These observations have
been largely reconciled by TopIB–DNA transition
state mimic structures and now the Cre–DNA transition
state mimic (Figure 3), all of which show this catalytic
arginine making hydrogen bonding interactions with
both a non-bridging phosphate (vanadate) oxygen and
with the O50 leaving group. Thus, Arg173 plays a dual
role in the transition state of the cleavage and ligation
reactions.
The results of our substitutions at Arg173 were
somewhat surprising. We had puriﬁed the R173K
mutant for a number of previous studies and have never
observed in vitro cleavage or recombination activity using
linear substrates. We therefore expected to ﬁnd that no
substitutions of Arg173 would result in recombination
activity above the threshold of our in vivo assay.
However, the R173K mutant is clearly active for recom-
bination in vivo. We do not yet understand why Cre
R173K is inactive in vitro, but we have previously shown
that this mutant is severely defective in synapsis of loxP
sites (26) and the corresponding R191K mutant in Flp
shows altered patterns of DNA-bending (40). It is conceiv-
able that substrate supercoiling or other diﬀerences in the
in vivo reaction (41) are able to compensate to some extent
for these deﬁciencies.
The second surprise was the relatively high activity
observed for R173H, a mutant that to our knowledge
has not been described for the tyrosine recombinases or
the TopIB enzymes. Unlike R173K, which showed no
in vitro recombination activity, the R173H mutant
showed robust activity both in vivo and in vitro. These
results suggest that a lack of interaction with the O50
leaving group is unlikely to be responsible for the
devastating loss of activity observed in other substitutions
at this position (e.g. R173A). The hydrogen bond to O50
made by R173 is via the Z2-nitrogen, at the very end of the
arginine side chain (Figure 3A). At best, the shorter histi-
dine side chain in this position would be capable of a
long-range interaction with O50 via its e-nitrogen. The
more likely active site conﬁguration for Cre R173H is
one where His173 hydrogen bonds to the O2P
non-bridging oxygen via Ne, just as Arg173 does in all
Cre–DNA crystal structures that have been reported.
Thus, the activity of R173H is most likely due to its
ability to stabilize a buildup of negative charge on O2P
rather than its ability to activate O50.
The R173H mutant also accumulates more HJ and
covalent intermediates of the reaction than are observed
for wild-type Cre. The accumulation of covalent inter-
mediate implies that Keq=kclv/klig (where kclv and klig
are the ﬁrst-order rate constants for cleavage and
ligation, respectively) has increased for the covalent inter-
mediates in the recombination pathway. Although Arg173
has been implicated in activation of the O50 leaving group,
the same interaction may also play a role in guiding O50
into position for eﬃcient ligation. Loss of this contribu-
tion could explain the mild ligation defect observed in the
R173H mutant. Interestingly, the Flp R191K mutant also
accumulates covalent intermediates in vitro, but in this
case the ligation defect is more severe and no recombinant
products are formed (40).
As shown in Table 3, most active site substitutions with
modest in vitro recombination activities generate more HJ
intermediate than wild-type Cre. Modeling of the recom-
bination pathway suggests that this general phenomenon
is most likely a consequence of a decrease in the rates of
strand exchange, extending the time window for persist-
ence of the HJ intermediate (data not shown). Analyses of
reaction time courses would be required to determine if
individual mutants are speciﬁcally defective in processing
the HJ intermediate.
We did not anticipate that the more conservative
R173K substitution would be less active than R173H.
As a possible explanation for this result, we suggest that
whereas histidine should be able to compensate for the
loss of the R173–O2P interaction, lysine may not eﬀect-
ively replace either function of R173. Modeling of a
Lys173 side chain in the transition state mimic active
site conﬁrms that the side chain is too short to interact
eﬀectively with O50 and also indicates that it may be too
long to form productive hydrogen-bonding interactions
with O2P if the more fully extended rotamers are used.
Alternative rotamers that would position the side chain
for more optimal hydrogen-bonding geometry with O2P
appear to introduce steric clashes with other active site
residues, perhaps explaining why this residue is ineﬀective
as an arginine substitute. An additional factor in the
relative activities of Lys173 versus His173 may involve
Glu176. As discussed below, Glu176 positions Arg173 in
the active site by hydrogen bonding to its backbone amide
and to its Z1-nitrogen. It is possible that His173 is simi-
larly positioned by Glu176 via its d-nitrogen.
Substitutions at Arg292
Sequence alignments indicate that Arg292 is as conserved
as Y324, with only a small number of lysine substitutions
represented (Table 1). Structures of Cre–DNA (11),   Int–
DNA (42,43) and Flp–DNA (44) complexes all show this
side chain hydrogen-bonding to the O1P non-bridging
oxygen via NZ2. Since lysine in this position should also
be capable of interacting with O1P (based on modeling), it
is not surprising that the corresponding R223K mutant in
vaccinia virus TopIB retains  10% activity (45). We also
found that the R292K mutant was moderately active.
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Arg292 that are weakly active in vivo. Of these, only the
histidine mutant shows detectable recombination in vitro.
The R292K substitution, on the other hand, is active both
in vivo and in vitro. This mutant also accumulates the most
covalent intermediate of any single active site substitution
that we have studied (Table 3), indicating a substantial
defect in substrate ligation. Similar observations have
been reported for the corresponding mutants in vaccinia
TopoIB (45), and XerCD (46).
The Cre–DNA–vanadate structure reveals a potentially
important interaction involving Arg292 that was not
evident in earlier recombinase–DNA crystal structures.
In addition to forming a hydrogen bond with O1P, the
arginine side chain hydrogen-bonds to the Tyr324
phenolic oxygen via Ne, forming a double
hydrogen-bonding contact resembling that observed for
Arg173 (but to diﬀerent functional groups). A similar
interaction was observed in the TopIB–vanadate struc-
tures (13,14), indicating that this is a conserved feature
of the transition state in the YR and TopIB enzymes. As
noted for the TopIB enzyme (47), the interaction of
Arg292 with the Tyr324 oxygen suggests that Arg292
could play a functional role in stabilizing the buildup of
negative charge of the phenolate form of the active site
tyrosine during the transition state of the reaction. The
accumulation of covalent intermediate by the R292K
mutant would be consistent with a role for Arg292 in ac-
tivation of the tyrosine leaving group during the ligation
reaction, since lysine in this position would not be
expected to form optimal interactions either with the
Tyr324 oxygen or with O1P for the same reasons discussed
above for the R173K mutant.
Substitutions at Trp315
Trp315 is an outlier among the YR enzymes in that >90%
of family members have histidine in this position
(Table 1). The Flp recombinase (and the small number
of recombinases from saccharomyces-related yeast that
harbor 2m plasmids) also uses Trp in this position (8). In
the covalent Cre–DNA complex crystal structure, Trp315
was observed hydrogen bonding to the O1P phosphate
oxygen via its indole nitrogen, leading to the prediction
that histidine most likely makes a similar interaction in the
related enzymes (30). Although this turned out to be true
for  -integrase (42) and for the TopIB enzymes (33,48),
subsequent work revealed that histidine is not eﬀective
when substituted for the corresponding tryptophan in
Flp (37) or in Cre (49). In both cases, the Phe substitutions
were reported to have higher activity than His in vitro and
the Ala substitutions were inactive. These studies,
combined with the structure of the Flp W330F–DNA
complex (37), led to a model where the primary role of
this residue involves buttressing the a-helix that contains
the tyrosine nucleophile and not transition state stabiliza-
tion via the indole-phosphate hydrogen bond.
Our analysis of Trp315 substitutions conﬁrms the
previous in vitro recombination data for Flp and Cre
and extends the list of highly active substitutions to
include tyrosine. In addition, we found that Ala, Gly,
Leu and Met substitutions all have weak in vivo recom-
bination activity. Of the weaker substitutions, His, Leu
and Met have detectable recombination activity in vitro
but the smaller Gly and Ala substitutions do not. The
ﬁnding that W315M has recombination activity compar-
able to W315H further underscores the need for a large
hydrophobic residue in this position. The in vivo activity of
W315A and W315G would appear to contradict this
model, but it is possible that these mutants adopt an
alternative conformation in this region of the enzyme
that is somehow able to partially compensate for the
loss of W315.
The positions of Trp315 and Tyr324 in the transition
state mimic structure (Figure 3) provide an opportunity to
carefully examine the contacts that are present at this
crucial stage of the reaction. Trp315 is located on a turn
between the aL and aM helices, where it provides a sub-
stantial amount of hydrophobic surface onto which the
aM helix docks via van der Waals interactions with
Ile320 and Val321. Tyr324 is located at the
carboxyl-terminus of aM, where the tyrosine ring ‘sits’
on top of Trp315. Each of the carbon atoms in the
Tyr324 phenyl ring contacts Cz of Trp315 with a
distance of 3.5–4A ˚ . Although the Phe and Tyr substitu-
tions are predicted to be less eﬀective than Trp in support-
ing the Tyr324 ring system, it is clear from modeling that a
similar set of substantial contacts could be made in the
transition state in both cases. Indeed, the structure of the
Flp W330F/DNA complex shows that this is the case
when the catalytic tyrosine has not yet attacked the
scissile phosphate (37). On the other hand, the smaller
histidine in this position does not appear to be capable
of forming similar contacts. We note that both the Phe
and Tyr substitutions at Trp315 cause substantial accumu-
lations of HJ intermediates (Table 3), suggesting that re-
packing this hydrophobic region of the enzyme may also
lead to conformational changes that inﬂuence aspects of
the reaction pathway other than catalysis.
If Trp315 plays a crucial role in positioning the active
site nucleophile, then it is instructive to consider how the
majority of tyrosine recombinases are able to function
with histidine in this position. In both Cre and Flp (and
most other YRs that use Trp in this position), glycine is
located two residues before His/Trp III. A side chain in
this position would occupy the same space as the trypto-
phan side chain in the absence of large structural changes
in the aL–aM turn. This residue is normally Leu, Met or
Val in most of the YR enzymes, each of which would
likely be able to fulﬁll the role of the active site tryptophan
in Cre and Flp. In   integrase, for example, a leucine
side chain in this position packs against the catalytic
tyrosine (42).
In those cases where a smaller side chain is located two
residues preceding His/Trp III, a large hydrophobic side
chain is present four residues after Arg292 in the aK helix.
This residue is normally an alanine in most YRs, but a
larger side chain would also project into the space
occupied by the bulky Trp side chain in Cre and Flp.
Thus, there appear to be a number of solutions for
stabilizing the local structure and deﬁning the position
of the active site nucleophile in the YR enzymes (49).
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substituted by Asn or Gln with only a modest loss of
activity (50). In this case, the helix containing Tyr274 is
anchored adjacent to the active site via direct contacts to
the DNA backbone and to bases downstream of the
cleavage site (14), so the role of this catalytic residue for
the TopIBs appears to primarily involve transition state
stabilization and not positioning of the active site tyrosine.
In the Flp recombinase, the W330A mutant shows an un-
expected thio eﬀect on 50-bridging phosphorothiolate sub-
strates, suggesting a role in leaving group activation (49).
This observation cannot be readily explained based on the
Cre transition state mimic structure.
His289 is unique to the tyrosine recombinases
The TopIB enzymes have no equivalent to His289 in their
active sites. Although lysine precedes Arg223 by three
residues in vaccinia and variola virus TopIB, diﬀerences
in local structure allow Lys220 to be directed away from
the scissile phosphate, where it instead interacts with the
upstream (+1) phosphate on the cleaved strand (48).
Consequently, the space occupied by His289 in the YRs
is ﬁlled with water molecules in the TopIB structures.
His289 is less strongly conserved among the tyrosine re-
combinases compared to the active site arginines and the
tyrosine ( 87%), with  7% of sequences showing Tyr in
this position and  1% with Gln. The original covalent
Cre–DNA structure prompted the suggestion that
His289 could be responsible for activation of Tyr324
during cleavage and ligation (30,51). Indeed, subsequent
crystal structures of Cre–DNA, Flp–DNA and   Int–
DNA complexes supported this idea. Biochemical
evidence for a role in general acid/base catalysis has
come from the Flp system, where synthetic peptides
with increased nucleophilicity of the catalytic tyrosine
were shown to rescue cleavage activity of the His305Q
mutant (52).
We found that all but ﬁve substitutions (Asp, Glu, Lys,
Arg and Trp) at His289 in Cre are active for recombin-
ation in vivo. Of these, Ile and Pro show only weak activity
but several are nearly as eﬃcient as wild-type Cre. All of
the mutants that were active in vivo also showed detectable
in vitro activity (Figure 5B). Two of the active mutants,
H289A and H289N, have been previously studied (53). In
the transition state mimic structure, His289 adopts a
curious hydrogen-bonding arrangement, with the Ne
hydrogen directed midway between non-bridging O2P
and the attacking/leaving oxygen of Tyr324. Thus,
His289 is positioned in such a way that it could stabilize
the buildup of negative charge on O2P and serve as a
proton donor/acceptor for the Tyr324 phenol oxygen. A
well-ordered water molecule (B-factor   18A ˚ 2) hydrogen
bonds to Nd of His289, an anchoring interaction that was
also observed in the covalent intermediate structure.
The variety of amino acid substitutions at His289,
which are active for recombination, indicates that
although moderately conserved, this active site residue is
not strictly required for catalysis. This idea is consistent
with the absence of an equivalent residue in the TopIB
enzymes. Glutamine is probably the most conservative
substitution for His289 in terms of size and ability to
hydrogen bond, yet the Met substitution has similar
activity in vivo and nearly the same activity in vitro.
Even the Gly substitution is moderately active. As
shown in Figure 5B and Table 3, both the Gln and Leu
substitutions at His289 lead to an accumulation of
covalent intermediate. This eﬀect was also observed for
several His305 mutants in Flp, including H305L (54).
Although one might conclude from an analysis of these
substitutions alone that His289 is required for eﬃcient
ligation, the data indicate that covalent intermediate ac-
cumulation is not a general property of His289 mutants.
The Ala, Gly, Met and Asn substitutions are all moder-
ately active, yet none of them appears to have shifted the
cleavage–ligation balance in favor of cleavage. The
H289M mutant does, however, accumulate a signiﬁcant
amount of HJ intermediate, with lesser amounts
produced by the Ala and Gly substitutions.
Interestingly, the Cre H289A mutant has also been
shown to have an altered preference for the strand of
loxP that is initially exchanged during recombination (53).
Of the inactive substitutions at His289, modeling indi-
cates that Trp is too bulky to be accommodated in the
active site without major changes in the positions of cata-
lytic residues. Asp and Glu would, in principle, be capable
of performing general acid/base catalysis, but the negative
charges associated with the carboxylate side chains are
clearly detrimental to recombination, presumably by
destabilizing the transition state. The lack of detectable
activity for the Lys and Arg substitutions was somewhat
surprising. One possible explanation is that these side
chains compete with Tyr324 for the same position
adjacent to the scissile phosphate and sterically block
the nucleophile. A large conformational change that
occurs in helix-M and Tyr324 relative to the inactive
active sites in the Cre tetramer suggests that this explan-
ation is plausible. Alternatively, the side chains may
simply be too long to be accommodated in the active
site. It does not appear possible for Lys289 or Arg289 to
adopt conformations that resemble Lys220 in the viral
TopIB structures due to steric interference with the
inter-domain linker that is quite diﬀerent in Cre
compared to the viral TopIB protein.
Glu176 organizes the active site
Glu176 does not interact directly with the scissile phos-
phate, but plays a role in organizing the Cre active site.
Although Glu is favored in this position of the YR family
(79%), Asp is also highly represented (16.4%), with over
95% using one or the other acidic side chain (Table 1). In
the transition state mimic structure, Glu176 accepts three
hydrogen bonds from catalytic residues. The side chain
carboxylate forms a hydrogen-bonding bridge between
the backbone amide and NZ1 of Arg173, appearing to
lock this key residue into a conformation that is optimal
for catalysis. The Glu176 carboxylate also hydrogen
bonds to the backbone amide of Lys201, helping to
position the b2–b3 loop in the minor groove adjacent to
the active site.
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acid in this position. In the   Int–DNA complex,
Asp215 anchors the b2–b3 loop by hydrogen bonding
with the backbone amide of Ser234 (which precedes the
conserved active site Lys235) and makes a long-range
interaction with Arg212–NZ1 (42,43). In the Flp–DNA
complex, Asp194 hydrogen bonds to the backbone
amide of Arg191 and interacts with the amide of Lys223
indirectly via bridging water molecules (55). Thus, Asp
and Glu in this position of the YR enzymes carry out
similar structural roles, but the detailed interactions
diﬀer among the individual systems. The TopIB enzymes
do not have a residue corresponding to Glu176 in Cre.
Instead, tightly bound water molecules in the active site
make a similar set of interactions with Arg130 and the
Lys167 backbone (13,14).
We found that 15 substitutions for Glu176 in Cre were
active for recombination in vivo, although the His, Met,
Pro, Val, Trp and Tyr substitutions were very weak.
In vitro, the His, Trp and Tyr mutants showed no detect-
able activity. Surprisingly, the strongest substitutions were
Asn and Thr, each of which showed high in vitro recom-
bination activity. The conservative E176D mutant was
somewhat less active and the E176Q mutant showed no
measurable activity at all in the in vitro assay. The
behavior of E176Q was unexpected; presumably this
residue stabilizes an alternative, but unproductive ar-
rangement of active site residues. The modest activities
resulting from Ala and Gly substitutions indicate that
loss of the interactions involving Arg173 and Lys201
diminishes, but does not destroy catalysis in this system.
Several substitutions for the corresponding Asp194 in
Flp recombinase have also been studied (Table S1). Of
these, it is interesting to note that the D194N mutant is
deﬁcient for cleavage of DNA half-sites (56). As noted
above, the corresponding conversion from acid to amide
in Cre is also defective. Although none of the Cre Glu176
mutants accumulates signiﬁcant amounts of covalent
intermediate, many of them do accumulate Holliday
intermediates.
DISCUSSION
The Cre active site residues can be grouped into three
categories based on their tolerance to substitution. In
the ﬁrst category, Tyr324 and Lys201 are essential for ca-
talysis; we found no active substitutions of Tyr324 and
only very weak ones for Lys201. Thus, a nucleophile
and a general acid catalyst to activate the 50-hydroxyl
leaving group play the most unique and essential roles in
the reaction. In the second group, Arg173 and Arg292
each play dual roles in catalysis and are symmetrically
organized in the transition state with respect to cleavage
and ligation. Both residues stabilize the buildup of
negative charge by hydrogen-bonding to a non-bridging
phosphate oxygen. These residues also hydrogen bond to
the nucleophile and leaving groups of the reaction: Arg173
to O50 and Arg292 to the Tyr324 hydroxyl. Thus, the roles
of the two residues become interchanged during cleavage
versus ligation. The third category includes Trp315,
His289 and Glu176, each of which is tolerant to substitu-
tions that result in moderate-to-high levels of recombin-
ation activity, with additional substitutions that have
lower levels of activity. No active site substitution
resulted in an increase in in vivo or in vitro recombination
activity relative to wild-type Cre.
For most active site residues, there is a high correlation
between the degree of substitution allowed and the diver-
sity of residues identiﬁed at the corresponding position in
the protein database. The exception is Arg173, which is
present as Arg in only 91% of the YR protein sequences.
Interestingly, the lysine substitution is found in only  1%
of the sequences and the remainder are distributed among
Ala, Ser and other residues. One explanation could be that
there are alternative active site compositions and/or
geometries that do not require the box I arginine for
activity. Alternatively, the YRs lacking Arg I may repre-
sent a group that is catalytically inactive, but has none-
theless retained Arg II and the active site tyrosine.
The active site residues most sensitive to substitution are
those shared by the TopIB enzymes, which catalyze the
same basic phosphoryl transfer reactions very eﬃciently
without His289 and Glu176 equivalents. Why, then, is
His II moderately conserved in the YR family and why
are Asp and Glu nearly always found in the position cor-
responding to Glu176? Part of the answer may be related
to the diﬀerences between the reactions catalyzed by the
YR and TopIB enzymes. The TopIBs cleave their targets
to form covalent 30-phosphotyrosine intermediates and
allow rotation of DNA downstream of the cleavage site
about the site of the nick. TopIB evolution has presum-
ably tuned the relative rates of cleavage and ligation to
strike a balance between allowing escape of the
50-nucleoside (and subsequent relaxation of supercoils)
and minimizing exposure of the nicked chromosome to
potentially damaging processes. In contrast, the YR
enzymes need to coordinate the cleavage, exchange and
ligation of DNA strands between two active sites in the
recombinase tetramer, while rendering the other two sites
inactive. In the absence of such allosteric regulation, YR
enzymes could generate double-strand breaks across the
6–8bp overlap region.
The details of the inter-subunit interactions responsible
for coordinating cleavage in the YR systems diﬀer consid-
erably among the Cre,   integrase and Flp systems.
However, one general feature in common to each of
these systems involves positioning of the active site
tyrosine, where availability of the nucleophile for catalysis
is strongly inﬂuenced by interactions with the neighboring
subunit (31,42,44,46). For Flp recombinase, the active site
tyrosine is donated in trans from an adjacent subunit (57).
An additional source of regulation may involve position-
ing of the active site lysine, which is also inﬂuenced by
inter-subunit contacts. One consequence of evolving a
regulated recombinase active site from an ancestral topo-
isomerase may therefore have been a loss of some catalytic
power, as the dynamics of active site residues were
modiﬁed in order to allow allosteric control of their pos-
itions. We suggest that the YR active site residues corres-
ponding to His289 and Glu176 in Cre were added in order
to compensate for this loss in activity. Indeed, loss of
Nucleic Acids Research, 2010,Vol.38, No. 17 5829either of these residues in Cre to generate a more
‘Topo-like’ active site results in a decrease in recombin-
ation activity and for those mutants in Cre and other
systems where cleavage has been assayed speciﬁcally, a
decrease in cleavage rates have been reported (Table S1).
Ironically, a comparison of the static transition state
models between the TopIB and YR enzymes might lead
to the conclusion that the YRs should be more eﬃcient in
catalyzing cleavage and ligation. In the Cre transition
state mimic structure, His289 provides both additional
transition state stabilization and a potential activating
function for Tyr324. Glu176 plays a structural role in pos-
itioning Arg173 and Lys201. In the corresponding variola
virus and trypanosomal TopIB transition state mimics,
these functional roles appear to be carried out by
ordered water molecules. However, estimates of the
pseudo-ﬁrst order cleavage rate constants for half-site
and full-site DNA substrates for Cre range from 0.001
to 0.003s
 1 (35,53,58), compared to 0.3 to 0.7s
 1 for
vaccinia virus TopIB (34,59). Flp recombinase, on the
other hand, cleaves half-site and full-site DNA at rates
that are closer to that of the TopIB enzymes (60). Thus,
the additional active site residues found in the YR
enzymes do not appear to provide a substantial increase
in their ability to cleave and ligate DNA substrates relative
to their TopIB cousins.
In addition to providing additional insight into the re-
lationship between the YR and TopIB enzymes, the data
presented here provide a basis for interpreting the results
of experiments involving TopIB and YR cleavage of DNA
substrates containing methylphosphonates at the scissile
phosphate positions (58,60,61). Vaccinia virus TopIB pref-
erentially cleaves DNA substrates with a scissle
Sp-methylphosphonate (Sp-MeP) over the Rp-MeP
diastereomer to form a covalent topo–DNA intermediate.
This intermediate is hydrolyzed at a rate that is four
orders of magnitude higher than observed with the
normal phosphotyrosine linkage, leading to the conclu-
sion that the negative charge on the phosphate (which is
reduced in the case of the methylphosphonate) plays a role
in protecting the covalent intermediate from hydrolysis
by repelling potential water nucleophiles (61). When
similar experiments were repeated with the Flp and
Cre recombinases, however, the stereospeciﬁcity of
methylphosphonate cleavage was found to be identical,
but there was no rate enhancement of hydrolysis of the
corresponding covalent intermediate (58,60).
A comparison of the Cre–DNA transition state mimic
with similar TopIB structures provides some insight
into these observations. In both Cre and TopIB, an
Sp-MeP (which corresponds to O1 in Figure 3 being
replaced by a methyl group) would generate a steric
clash with Arg292 (Cre)/Arg223 (TopIB) in the transition
state, requiring that this catalytic arginine be repositioned.
In the TopIB active site, a number of alternative
low-energy rotamers are available to Arg223. One of
these side chain conformations results in Arg223
straddling the Tyr274 leaving group oxygen, where it
can form two hydrogen bonds via Ne and NZ2. Thus,
part of the hydrolysis rate enhancement observed for the
TopIB enzyme could be due to an increase in leaving
group activation due to an alternative conformation of
Arg223. In the Cre and Flp active sites, this alternative
side chain conformation for Arg292/Arg308 is not
possible because His289/His305 (which is absent in the
TopIBs) sterically limits the number of arginine
rotamers than can be accommodated.
The active site substitutions that we have described,
when combined with transition state mimic structures of
Cre and TopIB, provide a useful foundation for
comparing the two systems and for understanding the re-
quirements for catalysis during Cre–loxP recombination
and presumably in the other YR family members as well.
In the YR systems, however, it is an oversimpliﬁcation to
think of the active site as being devoted entirely to cataly-
sis of cleavage and ligation. The Cre R173K and H289A
mutants are examples where this is clearly the case. Cre
R173K is defective in synapsis of loxP sites, which may
contribute to the lack of in vitro activity for this mutant. In
the structure of the pre-cleavage synaptic Cre–loxP
complex (using the Cre K201A mutant), Arg173
hydrogen bonds to the scissile phosphate in the ‘inactive
sites’, stabilizing a phosphate backbone conformation
adjacent to the asymmetric loxP bend (26). The H289A
mutant has the unexpected property of promoting a
top-strand-ﬁrst order of loxP strand exchanges during re-
combination, the opposite of that preferred by wild-type
Cre (53). His289 also plays an important role in the
inactive site of the synaptic complex, nucleating a
hydrogen-bonding network involving the Arg173
backbone, two water molecules and the active site phos-
phate (26). Related allosteric eﬀects have been reported in
the Xer system, where an R148K mutant in XerC is able
to stimulate the catalytic activity of XerD on HJ sub-
strates and vice versa (46). Thus, active site residues can
also strongly inﬂuence the reaction via interactions
involving the half-sites not undergoing catalysis.
Eﬀorts thus far to correlate biochemical activities with
structural models in the Cre, Flp and   Int systems
indicate that while the YRs have evolved strategies for
inter-subunit communication that share some overall
themes, they do diﬀer considerably in their molecular
details. This is especially apparent when comparing Flp
recombinase to the bacterial YRs, where the inter-subunit
contacts in the recombinase tetramers are quite diﬀerent.
Consequently, the roles of active site residues in mediating
the allosteric regulation of cleavage and ligation in these
enzymes are likely to diﬀer as well. An example of this can
be seen in a comparison of the Cre H289Q mutant with
the corresponding H305Q mutant in Flp. The Cre mutant
is nearly as active as wild-type Cre (this study), yet the Flp
H305Q mutant is severely defective (54). Dissection of
active site contributions to chemical catalysis versus
mediating the conformational changes and dynamics of
the recombinase tetramer through the recombination
pathway may therefore prove to be challenging.
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